Steady-state plasma and bronchopulmonary concentrations of intravenous levofloxacin and azithromycin in healthy adults

被引:93
作者
Rodvold, KA
Danziger, LH
Gotfried, MH
机构
[1] Univ Illinois, Coll Pharm, Chicago, IL 60612 USA
[2] Univ Illinois, Coll Med, Chicago, IL 60612 USA
[3] Univ Arizona, Sch Med, Tucson, AZ 85721 USA
[4] Pulm Associates, Phoenix, AZ USA
关键词
D O I
10.1128/AAC.47.8.2450-2457.2003
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The purpose of this study was to compare the concentrations of levofloxacin and azithromycin in steady-state plasma, epithelial lining fluid (ELF), and alveolar macrophage (AM) after intravenous administration. Thirty-six healthy, nonsmoking adult subjects were randomized to either intravenous levofloxacin (500 or 750 mg) or azithromycin (500 mg) once daily for five doses. Venipuncture and bronchoscopy with bronchoalveolar lavage were performed in each subject at either 4, 12, or 24 h after the start of the last antibiotic infusion. The mean concentrations of levofloxacin and azithromycin in plasma were similar to those previously published. The dosing regimens of levofloxacin achieved significantly (P < 0.05) higher concentrations in steady-state plasma than azithromycin during the 24 h after drug administration. The respective mean (+/- standard deviation) concentrations at 4, 12, and 24 h in ELF for 500 mg of levofloxacin were 11.01 +/- 4.52, 2.50 +/- 0.97, and 1.24 +/- 0.55 mu g/ml; those for 750 mg of levofloxacin were 12.94 +/- 1.21, 6.04 +/- 0.39, and 1.73 +/- 0.78 mu g/ml; and those for azithromycin were 1.70 +/- 0.74, 1.27 +/- 0.47, and 2.86 +/- 1.75 mu g/ml. The differences in concentrations in ELF among the two levofloxacin groups and azithromycin were significantly (P < 0.05) higher at the 4- and 12-h sampling times. The respective concentrations in AM for 500 mg of levofloxacin were 83.9 +/- 53.2, 18.3 +/- 6.7, and 5.6 +/- 3.2 mug/ml; those for 750 mg of levofloxacin were 81.7 +/- 37.0, 78.2 +/- 55.4, and 13.3 +/- 6.5 mug/ml; and those for azithromycin were 650 +/- 259, 669 +/- 311, and 734 +/- 770 mug/ml. Azithromycin achieved significantly (P < 0.05) higher concentrations in AM than levofloxacin at all sampling times. The concentrations in ELF and AM following intravenous administration of levofloxacin and azithromycin were higher than concentrations in plasma. Further studies are needed to determine the clinical significance of such high intrapulmonary concentrations in patients with respiratory tract infections.
引用
收藏
页码:2450 / 2457
页数:8
相关论文
共 43 条
[1]   Concentrations of levofloxacin (HR 355) in the respiratory tract following a single oral dose in patients undergoing fibre-optic bronchoscopy [J].
Andrews, JM ;
Honeybourne, D ;
Jevons, G ;
Brenwald, NP ;
Cunningham, B ;
Wise, R .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 (04) :573-577
[2]  
[Anonymous], 1983, Statistical Bulletin, Metropolitan Life Insurance Company, V64, P2
[3]   PULMONARY DISPOSITION OF ANTIMICROBIAL AGENTS - METHODOLOGICAL CONSIDERATIONS [J].
BALDWIN, DR ;
HONEYBOURNE, D ;
WISE, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (06) :1171-1175
[4]  
BALDWIN DR, 1990, EUR RESPIR J, V3, P886
[5]   PULMONARY DISPOSITION OF ANTIMICROBIAL AGENTS - INVIVO OBSERVATIONS AND CLINICAL RELEVANCE [J].
BALDWIN, DR ;
HONEYBOURNE, D ;
WISE, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (06) :1176-1180
[6]  
Bartlett John G., 2000, Clinical Infectious Diseases, V31, P347, DOI 10.1086/313954
[7]   INVITRO AND INVIVO INTRALEUKOCYTIC ACCUMULATION OF AZITHROMYCIN (CP-62, 993) AND ITS INFLUENCE ON EXVIVO LEUKOCYTE CHEMILUMINESCENCE [J].
BONNET, M ;
VANDERAUWERA, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (06) :1302-1309
[8]  
CAZZOLA M, 1994, INT J CLIN PHARM TH, V32, P88
[9]   Pharmacokinetic profile of levofloxacin following once-daily 500-milligram oral or intravenous doses [J].
Chien, SC ;
Rogge, MC ;
Gisclon, LG ;
Curtin, C ;
Wong, F ;
Natarajan, J ;
Williams, RR ;
Fowler, CL ;
Cheung, WK ;
Chow, AT .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (10) :2256-2260
[10]   OPEN-LABEL CROSSOVER STUDY TO DETERMINE PHARMACOKINETICS AND PENETRATION OF 2 DOSE REGIMENS OF LEVOFLOXACIN INTO INFLAMMATORY FLUID [J].
CHILD, J ;
MORTIBOY, D ;
ANDREWS, JM ;
CHOW, AT ;
WISE, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (12) :2749-2751